Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Docosahexaenoic Acid Inhibits PTP1B Phosphatase and the Viability of MCF-7 Breast Cancer Cells.

Kuban-Jankowska A, Gorska-Ponikowska M, Sahu KK, Kostrzewa T, Wozniak M, Tuszynski J.

Nutrients. 2019 Oct 23;11(11). pii: E2554. doi: 10.3390/nu11112554.

2.

Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.

Kostrzewa T, Sahu KK, Gorska-Ponikowska M, Tuszynski JA, Kuban-Jankowska A.

Drug Des Devel Ther. 2018 Dec 5;12:4139-4147. doi: 10.2147/DDDT.S186614. eCollection 2018.

3.

Omega-3 Polyunsaturated Fatty Acids Time-Dependently Reduce Cell Viability and Oncogenic MicroRNA-21 Expression in Estrogen Receptor-Positive Breast Cancer Cells (MCF-7).

LeMay-Nedjelski L, Mason-Ennis JK, Taibi A, Comelli EM, Thompson LU.

Int J Mol Sci. 2018 Jan 14;19(1). pii: E244. doi: 10.3390/ijms19010244.

5.

Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.

Kuban-Jankowska A, Sahu KK, Gorska-Ponikowska M, Tuszynski JA, Wozniak M.

Anticancer Res. 2017 Sep;37(9):4799-4806.

PMID:
28870898
6.

Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK.

Am J Clin Nutr. 2010 May;91(5):1185-94. doi: 10.3945/ajcn.2009.29036. Epub 2010 Mar 24.

7.

Lipoic Acid Decreases the Viability of Breast Cancer Cells and Activity of PTP1B and SHP2.

Kuban-Jankowska A, Gorska-Ponikowska M, Wozniak M.

Anticancer Res. 2017 Jun;37(6):2893-2898.

PMID:
28551626
9.

PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model.

Przychodzen P, Kuban-Jankowska A, Wyszkowska R, Barone G, Bosco GL, Celso FL, Kamm A, Daca A, Kostrzewa T, Gorska-Ponikowska M.

Toxicol In Vitro. 2019 Dec;61:104624. doi: 10.1016/j.tiv.2019.104624. Epub 2019 Aug 13.

PMID:
31419504
10.

Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential.

Kostrzewa T, Przychodzen P, Gorska-Ponikowska M, Kuban-Jankowska A.

Anticancer Res. 2019 Feb;39(2):745-749. doi: 10.21873/anticanres.13171.

PMID:
30711953
12.

Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation.

Roy J, Oliveira LT, Oger C, Galano JM, Bultel-Poncé V, Richard S, Guimaraes AG, Vilela JM, Andrade MS, Durand T, Besson P, Mosqueira VC, Le Guennec JY.

J Exp Clin Cancer Res. 2015 Dec 21;34:155. doi: 10.1186/s13046-015-0273-z.

13.

Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.

Rescigno T, Capasso A, Tecce MF.

J Cell Physiol. 2016 Jun;231(6):1226-36. doi: 10.1002/jcp.25217. Epub 2015 Oct 26.

PMID:
26480024
14.

Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer.

Liao SC, Li JX, Yu L, Sun SR.

J Zhejiang Univ Sci B. 2017 Apr.;18(4):334-342. doi: 10.1631/jzus.B1600184.

15.

Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models.

VanderSluis L, Mazurak VC, Damaraju S, Field CJ.

Int J Mol Sci. 2017 Dec 4;18(12). pii: E2607. doi: 10.3390/ijms18122607. Review.

16.

A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines.

Skibinski CG, Das A, Chen KM, Liao J, Manni A, Kester M, El-Bayoumy K.

Chem Biol Interact. 2016 May 25;252:1-8. doi: 10.1016/j.cbi.2016.03.035. Epub 2016 Apr 1.

PMID:
27041074
17.

Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells.

Chen HW, Chao CY, Lin LL, Lu CY, Liu KL, Lii CK, Li CC.

Arch Toxicol. 2013 May;87(5):857-69. doi: 10.1007/s00204-012-1003-3. Epub 2013 Jan 4.

PMID:
23288142
18.

Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.

Barone I, Giordano C, Malivindi R, Lanzino M, Rizza P, Casaburi I, Bonofiglio D, Catalano S, Andò S.

Endocrinology. 2012 Nov;153(11):5157-66. doi: 10.1210/en.2012-1561. Epub 2012 Sep 7.

PMID:
22962253
19.

Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.

Harvey KA, Xu Z, Saaddatzadeh MR, Wang H, Pollok K, Cohen-Gadol AA, Siddiqui RA.

J Neurosurg. 2015 Mar;122(3):547-56. doi: 10.3171/2014.10.JNS14759. Epub 2014 Dec 19.

PMID:
25526274
20.

Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.

Amiano P, Machón M, Dorronsoro M, Chirlaque MD, Barricarte A, Sánchez MJ, Navarro C, Huerta JM, Molina-Montes E, Sánchez-Cantalejo E, Urtizberea M, Arriola L, Larrañaga N, Ardanaz E, Quirós JR, Moreno-Iribas C, González CA.

Nutr Metab Cardiovasc Dis. 2014 Mar;24(3):321-7. doi: 10.1016/j.numecd.2013.08.011. Epub 2013 Dec 20.

PMID:
24360762

Supplemental Content

Support Center